Sensus Healthcare, Inc.
SRTSNasdaqCIK 1494891HealthcareFiscal year ends Dec 31
Reports and events: 139 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1411:55 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001753926-26-001508 |
| 2026-08-1316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-26-001479 |
| 2026-06-0516:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001753926-26-000983 |
| 2026-06-0208:26 ET | 8-K | 5.07 Shareholder vote results | 0001753926-26-000960 |
| 2026-05-1314:48 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001753926-26-000845 |
| 2026-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-26-000782 |
| 2026-04-2916:11 ET | DEF 14A | Proxy statementPeriod 2026-05-29 | 0001753926-26-000749 |
| 2026-03-0412:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001753926-26-000435 |
| 2026-02-1216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-26-000315 |
| 2026-01-2011:07 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001753926-26-000147 |
| 2026-01-1219:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001753926-26-000088 |
| 2025-11-1310:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001753926-25-001772 |
| 2025-11-1214:56 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001753926-25-001745 |
| 2025-11-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-25-001710 |
| 2025-08-1214:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001753926-25-001290 |
| 2025-08-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-25-001254 |
| 2025-06-0216:20 ET | 8-K | 5.07 Shareholder vote results | 0001753926-25-000919 |
| 2025-05-1516:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001753926-25-000853 |
| 2025-05-1516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-25-000851 |
| 2025-04-2916:02 ET | DEF 14A | Proxy statementPeriod 2025-05-27 | 0001753926-25-000705 |
| 2025-03-0515:56 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001753926-25-000408 |
| 2025-02-1109:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000213 |
| 2025-02-0516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-25-000183 |
| 2024-11-1812:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-099516 |
| 2024-11-1413:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098193 |
| 2024-11-1412:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-098068 |
| 2024-09-1116:01 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-24-077707 |
| 2024-08-1314:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068165 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-066621 |
| 2024-06-0516:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-050044 |
| 2024-05-3121:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-048133 |
| 2024-05-1012:23 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-041605 |
| 2024-05-0916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-041314 |
| 2024-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2024-05-31 | 0001213900-24-037153 |
| 2024-03-1516:41 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-023093 |
| 2024-02-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-011598 |
| 2024-02-0216:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-009622 |
| 2024-01-1816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-24-004491 |
| 2023-11-1317:22 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086237 |
| 2023-11-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-085220 |
| 2023-09-1416:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-076674 |
| 2023-08-1112:56 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-066051 |
| 2023-08-1109:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-065938 |
| 2023-08-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-062982 |
| 2023-06-0616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-046768 |
| 2023-05-1215:29 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-038952 |
| 2023-05-0316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-035978 |
| 2023-05-0108:00 ET | DEF 14A | Proxy statementPeriod 2023-06-02 | 0001213900-23-034173 |
| 2023-03-2314:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-022355 |
| 2023-02-0916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-009738 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.